In recent days, Cathie Wood’s ARK Invest has materially increased its holdings in Beam Therapeutics, adding more than 195,000 ...

Smart AI governance isn’t about locking systems down or letting them run wild — it’s about giving teams freedom with just ...

AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...

Agrivoltaic project developer Okovate Sustainable Energy has acquired the assets of Fundusol, a modeling platform born out of ...

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

Okovate Sustainable Energy, Inc., has announced the successful acquisition of the assets of Fundusol, a modeling platform born out of Stanford University and Carnegie Mellon.

Alumis is firmly in focus after announcing positive topline results from two Phase 3 trials (ONWARD1 and ONWARD2) evaluating envudeucitinib , its next-generation oral TYK2 inhibitor, in ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

University of Otago scientists are harnessing the power of peptides—the body's own tiny protein molecules—for a spray to help ...

The Universidad Carlos III de Madrid (UC3M) inaugurated today its Scientific Computing Center (C3), a new state-of-the-art supercomputing facility designed to support R&D&I projects with high demands ...

Computers found what human experts missed: a divide between aging biology research and patient care that decades of funding ...